Enanta Pharmaceuticals(ENTA) - 2022 Q2 - Earnings Call Transcript
Enanta Pharmaceuticals(ENTA)2022-05-10 01:14Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Jennifer Viera - Director of IR & Corporate Communications Jay Luly - President and CEO Paul Mellett - CFO Nathalie Adda - Consultant Tara Kieffer - SVP, New Product Strategy & Development Conference Call Participants Luke Herrmann - Robert W. Baird Brian Abrahams - RBC Capital Markets Swapnil Malekar - Piper Sandler Akash Tewari - Jefferies Roy Buchanan - JMP Securities Hannah Adeoye - ...